{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:04:36Z","timestamp":1782475476076,"version":"3.54.5"},"reference-count":28,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives of Disease in Childhood"],"published-print":{"date-parts":[[1988,3,1]]},"DOI":"10.1136\/adc.63.3.250","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T22:13:07Z","timestamp":1229983987000},"page":"250-255","source":"Crossref","is-referenced-by-count":66,"title":["Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia."],"prefix":"10.1136","volume":"63","author":[{"given":"S","family":"De Virgiliis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Congia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Frau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Dessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Argiolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sorcinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sitzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1056\/NEJM197708252970804","article-title":"Continuous subcutaneous administration of desferrioxamine in patients with iron overload","volume":"297","author":"Propper, R.D.; Cooper, B.; Rufo, R.R.","year":"1977","unstructured":"Propper RD, Cooper B, Rufo RR, et al. Continuous subcutaneous administration of desferrioxamine in patients with iron overload. N Engl J Med 1977;297:418-23.","journal-title":"N Engl J Med"},{"key":"ref_2","first-page":"648","article-title":"Chelation therapy in 3-thalassemia major","volume":"92","author":"true","year":"1978","unstructured":"Graziano JH, Markenson A, Miller DR, et al. Chelation therapy in 3-thalassemia major. I. Intravenous and subcutaneous deferoxamine. J Pediatr 1978;92:648-52.","journal-title":"I. Intravenous and subcutaneous deferoxamine. J Pediatr"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(81)80385-X","article-title":"Response to long term desferrioxamine therapy in thalassemia","volume":"99","author":"Cohen, A.; Martin, M.; Schwartz, E.","year":"1981","unstructured":"Cohen A, Martin M, Schwartz E. Response to long term desferrioxamine therapy in thalassemia. J Pediatr 1981;99: 689-94.","journal-title":"J Pediatr"},{"issue":"108 1","key":"ref_4","article-title":"Survival and desferrioxamine in thalassemia major","volume":"284","author":"Modell, B.; Letzky, A.E.; Flynn, D.M.; Peto, R.; Weatherall, D.J.","year":"1982","unstructured":"Modell B, Letzky AE, Flynn DM, Peto R, Weatherall DJ. Survival and desferrioxamine in thalassemia major. Br Med J 1982;284:108 1.","journal-title":"Br Med J"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/adc.57.12.929","article-title":"Early iron overload in 13-thalassaemia major: when to start chelation therapy?","volume":"57","author":"Fargion, S.; Taddei, M.T.; Gabutti, V.","year":"1982","unstructured":"Fargion S, Taddei MT, Gabutti V, et al. Early iron overload in 13-thalassaemia major: when to start chelation therapy? Arch Dis Child 1982;57:929-33.","journal-title":"Arch Dis Child"},{"key":"ref_6","first-page":"73","article-title":"Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients","volume":"5","author":"S, De Virgiliis; P, Cossu; C, Toccafondi","year":"1983","unstructured":"De Virgiliis S, Cossu P, Toccafondi C, et al. Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients. Am J Pediatr Hemnatol Oncol 1983;5:73-7.","journal-title":"Am J Pediatr Hemnatol Oncol"},{"key":"ref_7","first-page":"181","article-title":"Ocular toxicity of high dose intravenous desferrioxamine","volume":"ii:","author":"Davies, S.C.; Marcus, R.E.; Hungerford, J.L.; Miller, M.H.; Arden, G.B.; Huehns, E.R.","year":"1983","unstructured":"Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER. Ocular toxicity of high dose intravenous desferrioxamine. Lancet 1983;ii:181-4.","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/08880018509141202","article-title":"Iron elimination following intravenous desferrioxamine infusion in patients with thalassemia major","volume":"2","author":"De Virgiliis S, Frau F, Sanna G","year":"1985","unstructured":"De Virgiliis S, Frau F, Sanna G, et al. Iron elimination following intravenous desferrioxamine infusion in patients with thalassemia major. European Paediatric HaematolylOncology 1985;2: 47-8.","journal-title":"European Paediatric HaematolylOncology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM198604033141402","article-title":"Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions","volume":"314","author":"Olivieri, N.F.; Buncic, JR, Chew; E.","year":"1986","unstructured":"Olivieri NF, Buncic JR, Chew E, et al. Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 1986;314:869-73.","journal-title":"N Engl J Med"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/096032718600500403","article-title":"Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane","volume":"5","author":"Arden, G.B.","year":"1986","unstructured":"Arden GB. Desferrioxamine administered intravenously by infusion causes a reduction in the electroretinogram in rabbits anaesthetized with urethane. Hum Toxicol 1986;5:229-36.","journal-title":"Hum Toxicol"},{"key":"ref_11","first-page":"95","article-title":"Desferrioxamine and trace metal excretion in chelation therapy in chronic iron overload","volume-title":"chronic iron overload","author":"Zaino, E.C.","year":"1977","unstructured":"Zaino EC. Desferrioxamine and trace metal excretion in chelation therapy in chronic iron overload. In: Zaino EC, Roberts RH, eds. Chelation and chronic iron overload. New York: Ciba Medical Horizons Symposium, 1977:95-107."},{"key":"ref_12","first-page":"34","article-title":"Ocular electrophysiology","author":"Babel, J.M.; Stangos, M.; Korol, S.; Spiritus, M.","year":"1977","unstructured":"Babel JM, Stangos M, Korol S, Spiritus M. Ocular electrophysiology. Stuttgart: G Thiene Publishers, 1977:34-5."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00144160","article-title":"The human electroretinogram in the light and during dark adaptation","volume":"22","author":"Auerbach, E.","year":"1967","unstructured":"Auerbach E. The human electroretinogram in the light and during dark adaptation. Doc Ophthalmol 1967;22:1-4.","journal-title":"Doc Ophthalmol"},{"key":"ref_14","first-page":"177","article-title":"The estimation of intestinal alkaline phosphatase in human blood serum","volume":"25","author":"It-Koon, T.; Moss, D.W.","year":"1969","unstructured":"It-Koon T, Moss DW. The estimation of intestinal alkaline phosphatase in human blood serum. Clin Chim Acta 1969;25: 177-9.","journal-title":"Clin Chim Acta"},{"key":"ref_15","first-page":"21","article-title":"A one stage procedure for isolation of granulocytes and lymphocytes from human blood","volume":"97","author":"Boyum, A.","year":"1968","unstructured":"Boyum A. A one stage procedure for isolation of granulocytes and lymphocytes from human blood. Scand J Clin Lab Invest 1968;97(suppl 21):51-3.","journal-title":"Scand J Clin Lab Invest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0161-6420(84)34267-1","article-title":"Deferoxamine (Desferal) induced toxic retinal pigmentary degeneration and presumed optic neuropathy","volume":"91","author":"Lakhanpal, V.; Schocket, S.S.; Jiji, R.","year":"1984","unstructured":"Lakhanpal V, Schocket SS, Jiji R. Deferoxamine (Desferal) induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology 1984;91:443-51.","journal-title":"Ophthalmology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ajcn\/41.4.689","article-title":"Circandian variations in serum zinc (Zn) concentrations: correlation with blood ionized calcium, serum total calcium and phosphate in humans","volume":"41","author":"Markowitz, M.E.; Rosen, J.F.; Mizruchi, M.","year":"1985","unstructured":"Markowitz ME, Rosen JF, Mizruchi M. Circandian variations in serum zinc (Zn) concentrations: correlation with blood ionized calcium, serum total calcium and phosphate in humans. Am J Clin Nutr 1985;41:689-96.","journal-title":"Am J Clin Nutr"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1182\/blood.V60.2.288.288","article-title":"Ferrioxamine excretion in iron-loaded man","volume":"60","author":"Pippard, M.J.; Callender, S.T.; Finch, C.A.","year":"1982","unstructured":"Pippard MJ, Callender ST, Finch CA. Ferrioxamine excretion in iron-loaded man. Blood 1982;60:288-94.","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1753-4887.1983.tb07155.x","article-title":"Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update","volume":"41","author":"Prasad, A.S.","year":"1983","unstructured":"Prasad AS. Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update. Nut Rev 1983;41:197-208.","journal-title":"Nut Rev"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0039-6257(82)90195-3","article-title":"Zinc in the eye","volume":"27","author":"Karciogluo, Z.A.","year":"1982","unstructured":"Karciogluo ZA. Zinc in the eye. Surv Ophthalmol 1982;27: 114-22.","journal-title":"Surv Ophthalmol"},{"key":"ref_21","first-page":"425","article-title":"The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium","volume":"23","author":"Leure-dePree, A.E.; McClain, C.J.","year":"1982","unstructured":"Leure-dePree AE, McClain CJ. The effect of severe zinc deficiency on the morphology of the rat retinal pigment epithelium. Invest Ophthalmol Vis Sci 1982;23:425-34.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref_22","first-page":"1","article-title":"Zinc deficiency and visual dysfunction","volume":"3","author":"Wong Jr EK, Leopold IH","year":"1979","unstructured":"Wong Jr EK, Leopold IH. Zinc deficiency and visual dysfunction. Metabolic and Pediatric Ophthalmology 1979;3:1-4.","journal-title":"Metabolic and Pediatric Ophthalmology"},{"key":"ref_23","first-page":"189","article-title":"Abnormal dark adaptation in sickle cell anemia","volume":"98","author":"Warth, J.A.; Prasad, A.S.; Zwas, F.; Frank, R.N.","year":"1981","unstructured":"Warth JA, Prasad AS, Zwas F, Frank RN. Abnormal dark adaptation in sickle cell anemia. J Lab Clin Med 1981;98: 189-94.","journal-title":"J Lab Clin Med"},{"key":"ref_24","first-page":"187","article-title":"Plasma zinc levels in high myopia and retinitis pigmentosa","volume":"5","author":"Silverstone, B.Z.; Bursen, N.; D, Seelenfreund; M.H.","year":"1981","unstructured":"Silverstone BZ, N.Bursen D, Seelenfreund MH. Plasma zinc levels in high myopia and retinitis pigmentosa. Medical and Pediatric Ophthalmology 1981;5:187-90.","journal-title":"Medical and Pediatric Ophthalmology"},{"key":"ref_25","first-page":"345","article-title":"Cerebral and ocular toxicity induced by desferrioxamine","volume":"56","author":"Blake, D.R.; Winyard, P.; Lunec, J.","year":"1985","unstructured":"Blake DR, Winyard P, Lunec J, et al. Cerebral and ocular toxicity induced by desferrioxamine. Q J Med 1985;56:345-55.","journal-title":"Q J Med"},{"key":"ref_26","first-page":"351","article-title":"Fluorescent products of phospholipid peroxidation: Formation and inhibition in model systems","volume-title":"lipofuscinosis (Batten's disease","author":"Gutteridge, J.M.C.","year":"1982","unstructured":"Gutteridge JMC. Fluorescent products of phospholipid peroxidation: Formation and inhibition in model systems. In: Armstrong D, Koppang N, Rider JA, eds. Ceroid lipofuscinosis (Batten's disease). Amsterdam: Elsevier, Biomedical Press, 1982:351-64."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0006-2952(85)90492-7","article-title":"Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization","volume":"34","author":"Laub, R.; Schneider, Y.J.; Octave, J.N.; Trouet, A.; Crichton, R.R.","year":"1985","unstructured":"Laub R, Schneider YJ, Octave JN, Trouet A, Crichton RR. Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization. Biochem Pharmacol 1985;34:1175-83.","journal-title":"Biochem Pharmacol"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/bjo.68.12.873","article-title":"Ocular changes in patients undergoing long-term desferrioxamine treatment","volume":"68","author":"Arden, G.B.; Wonke, B.; Kennedy, C.; Huehns, E.R.","year":"1984","unstructured":"Arden GB, Wonke B, Kennedy C, Huehns ER. Ocular changes in patients undergoing long-term desferrioxamine treatment. Br J Ophthalmol 1984;68:873-77.","journal-title":"Br J Ophthalmol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.63.3.250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:00:44Z","timestamp":1601078444000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/adc.63.3.250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1988,3,1]]}},"URL":"https:\/\/doi.org\/10.1136\/adc.63.3.250","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,3,1]]}}}